Drug-eluting stents and their additional benefit to low-risk patients were investigated in a cost-effectiveness analysis presented to the Stockholm cardiology meeting by Matthias Pfisterer from Basel. Audio Medica talked with him.
[audio:https://www.audiomedica.com/podcasting/14.Matt_Pfisterer-Drug-eluting_stents_may_confer_so_little_additional_benefit_to_low_risk_patients.mp3]
Eight Blood Pressure Genes Bring Promise For Drug Design 29 Jun, 2009 Protective Cardiovascular Benefit for Women on HRT For Natural Menopause 6 Nov, 2007 
Reversible ADP Antagonists: New Alternatives To Clopidogrel For Anti-Platelet Therapy In Elective PCI 24 Nov, 2009 Audio Journal of Cardiovascular Medicine 12.1, January 2006 10 Jan, 2006 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014